Report shares new details about death possibly linked to experimental Alzheimer's drug https://ift.tt/mWYbtXx The death of a participant in a clinical trial of an antibody treatment for Alzheimer's disease, which is now under consideration by the US Food and Drug Administration, may be linked to the experimental drug, a new report shows.